ENvue Medical registers resale of 6,000,768 shares by selling stockholder; company gets no proceeds

Filed May 28, 2026 · ~1 min read

Key Changes

• high

  The prospectus covers resale of up to 6,000,768 common shares issuable upon conversion of Series H Preferred Stock held by a selling stockholder.

  The Offering verify on EDGAR →
• high

  Series H Preferred has stated value $1,000 per share and converts at $1.0422 per share, implying ~959.6 common shares per preferred share.

  The Offering verify on EDGAR →
• high

  The company will not receive any proceeds from the sale of shares by the selling stockholder.

  The Offering verify on EDGAR →